Solventum Corporation (NYSE:SOLV) Receives Average Rating of “Hold” from Analysts

Shares of Solventum Corporation (NYSE:SOLV) have been assigned a consensus rating of “Hold” from the fourteen analysts that are currently covering the company, Marketbeat reports. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and seven have assigned a buy rating to the company. The average 12-month price target among analysts that have issued ratings on the stock in the last year is $90.8333.

Several equities analysts recently commented on SOLV shares. KeyCorp raised shares of Solventum from a “sector weight” rating to an “overweight” rating and set a $97.00 price target for the company in a research report on Monday, January 26th. Wall Street Zen cut shares of Solventum from a “buy” rating to a “hold” rating in a research note on Saturday, February 7th. Mizuho set a $100.00 price objective on Solventum and gave the stock an “outperform” rating in a report on Tuesday, January 20th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Solventum in a research report on Tuesday, January 27th. Finally, Stifel Nicolaus boosted their price target on Solventum from $88.00 to $105.00 and gave the company a “buy” rating in a research report on Wednesday, January 7th.

Solventum Stock Performance

Solventum stock opened at $75.59 on Friday. The stock has a fifty day moving average price of $80.01 and a 200 day moving average price of $76.08. Solventum has a 52 week low of $60.70 and a 52 week high of $88.20. The firm has a market capitalization of $13.11 billion, a P/E ratio of 8.71, a PEG ratio of 6.97 and a beta of 0.35. The company has a current ratio of 1.50, a quick ratio of 1.14 and a debt-to-equity ratio of 1.03.

Solventum announced that its Board of Directors has initiated a share buyback program on Thursday, November 20th that permits the company to buyback $1.00 billion in shares. This buyback authorization permits the company to buy up to 7.5% of its stock through open market purchases. Stock buyback programs are generally a sign that the company’s board believes its shares are undervalued.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Nisa Investment Advisors LLC raised its holdings in shares of Solventum by 0.6% during the 2nd quarter. Nisa Investment Advisors LLC now owns 33,974 shares of the company’s stock valued at $2,577,000 after buying an additional 210 shares during the period. South Dakota Investment Council boosted its holdings in Solventum by 3.6% in the 2nd quarter. South Dakota Investment Council now owns 255,625 shares of the company’s stock worth $19,387,000 after acquiring an additional 8,960 shares during the period. Purus Wealth Management LLC acquired a new stake in Solventum in the second quarter valued at approximately $252,000. Terril Brothers Inc. grew its position in Solventum by 15.3% in the second quarter. Terril Brothers Inc. now owns 96,516 shares of the company’s stock valued at $7,320,000 after acquiring an additional 12,800 shares in the last quarter. Finally, Jennison Associates LLC purchased a new stake in shares of Solventum during the second quarter valued at approximately $3,076,000.

About Solventum

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes.